Peritoneal mononuclear cell differentiation and cytokine production in intermittent and continuous automated peritoneal dialysis

Eike Wrenger(Medizinische Hochschule Hannover), R. Brunkhorst(Klinikum Region Hannover), Martin Behrend(Otto-von-Guericke-Universität Magdeburg), Cory W. Baumann(Otto-von-Guericke-Universität Magdeburg), E. Zamore(Medizinische Hochschule Hannover), Ralf Schindler(Charité - Universitätsmedizin Berlin)

American Journal of Kidney Diseases

February 1, 1998

10.1053/ajkd.1998.v31.pm9469493

Cited by 21

Related Papers

Epidemiology of sepsis in Germany: results from a national prospective multicenter study

|Intensive Care Medicine|2007|623

Validation of treatment strategies for enterohaemorrhagic Escherichia coli O104:H4 induced haemolytic uraemic syndrome: case-control study

|BMJ|2012|309

First Human Trial of FTY720, a Novel Immunomodulator, in Stable Renal Transplant Patients

|Journal of the American Society of Nephrology|2002|274

Intravenous pulse administration of cyclophosphamide versus daily oral treatment in patients with antineutrophil cytoplasmic antibody-associated vasculitis and renal involvement: A prospective, randomized study

|Arthritis & Rheumatism|1998|261

Best supportive care and therapeutic plasma exchange with or without eculizumab in Shiga-toxin-producing E. coli O104:H4 induced haemolytic–uraemic syndrome: an analysis of the German STEC-HUS registry

|Nephrology Dialysis Transplantation|2012|239